BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1723537)

  • 41. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

  • 42. Expression of HLA-DR (major histocompatibility complex class II) on neutrophils from patients treated with granulocyte-macrophage colony-stimulating factor for mobilization of stem cells.
    Mudzinski SP; Christian TP; Guo TL; Cirenza E; Hazlett KR; Gosselin EJ
    Blood; 1995 Sep; 86(6):2452-3. PubMed ID: 7545027
    [No Abstract]   [Full Text] [Related]  

  • 43. Morphologic and quantitative alterations in hematopoietic cells associated with growth factor therapy: review of the literature.
    Schmitz LL; Litz CE; Brunning RD
    Hematol Pathol; 1994; 8(3):55-73. PubMed ID: 7527020
    [No Abstract]   [Full Text] [Related]  

  • 44. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
    Hast R; Bernell P
    Acta Haematol Pol; 1991; 22(2):203-7. PubMed ID: 1726768
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical use of hematopoietic growth factors].
    Robak T
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
    [No Abstract]   [Full Text] [Related]  

  • 46. Autologous stem cell transplantation: exogenous granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor modulate the endogenous cytokine levels.
    Testa U; Martucci R; Scambia G; Panici PB; Mancuso S; Camagna A; Mastroberardino G; Pierelli L; Menichella G; Peschle C
    Blood; 1997 Apr; 89(7):2615-7. PubMed ID: 9116312
    [No Abstract]   [Full Text] [Related]  

  • 47. PIXY321 (GM-CSF/IL-3 fusion protein): biology and early clinical development.
    Vadhan-Raj S
    Stem Cells; 1994 May; 12(3):253-61. PubMed ID: 8075592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 49. Hematopoietic growth factors in AIDS.
    Groopman JE; Feder D
    Semin Oncol; 1992 Aug; 19(4):408-14. PubMed ID: 1380730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hematopoietic growth factors for the mobilization of peripheral blood stem cells.
    Haas R; Hohaus S; Goldschmidt H; Witt B; Hunstein W
    J Hematother; 1993; 2(3):357-9. PubMed ID: 7522890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
    St Onge J; Jacobson RJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
    [No Abstract]   [Full Text] [Related]  

  • 52. Synergistic effects of basic fibroblast growth factor and hematopoietic growth factors on colony formation of K562 human leukemic cells.
    Komatsu K; Nakamura H; Masaoka T; Akedo H
    Leukemia; 1995 Sep; 9(9):1565-8. PubMed ID: 7544854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of growth hematopoietic factors in AIDS.
    Groopman JE
    Pathol Biol (Paris); 1992 Nov; 39(9):874-5. PubMed ID: 1371606
    [No Abstract]   [Full Text] [Related]  

  • 54. Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis.
    Peters BG; Adkins DR; Harrison BR; Velasquez WS; Dunphy FR; Petruska PJ; Bowers CE; Niemeyer R; McIntyre W; Vrahnos D; Auberry SE; Spitzer G
    Bone Marrow Transplant; 1996 Jul; 18(1):93-102. PubMed ID: 8832001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytokine use in the management of HIV disease.
    Scadden DT
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 16 Suppl 1():S23-9. PubMed ID: 9389312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cellular basis for enhancement interactions between stem cell factor and the colony stimulating factors.
    Metcalf D
    Stem Cells; 1993 Jul; 11 Suppl 2():1-11. PubMed ID: 7691313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
    Merchav S; Wagemaker G; Souza LM; Tatarsky I
    Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Supplying the demand for granulocytes.
    Kincade PW
    Nat Immunol; 2006 Jul; 7(7):701-2. PubMed ID: 16785885
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PIXY 321 (GM-CSF/IL-3 fusion protein).
    Secola R
    J Pediatr Oncol Nurs; 1993 Jul; 10(3):117-8. PubMed ID: 8397971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.